F2RL3
Proteinase-activated receptor 4
Also known as: PAR4, PAR4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96RI0
- Gene
- F2RL3
- Ensembl
- ENSG00000127533
- Chromosome
- 19
- Canonical length
- 385 aa
- Protein class
- G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the protease-activated receptor subfamily, part of the G-protein coupled receptor 1 family of proteins. The encoded receptor is proteolytically processed to reveal an extracellular N-terminal tethered ligand that binds to and activates the receptor. This receptor plays a role in blood coagulation, inflammation and response to pain. Hypomethylation at this gene may be associated with lung cancer in human patients. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
385 residues, UniProt reviewed canonical sequence.
>Q96RI0|F2RL3
1 MWGRLLLWPL VLGFSLSGGT QTPSVYDESG STGGGDDSTP SILPAPRGYP GQVCANDSDT
61 LELPDSSRAL LLGWVPTRLV PALYGLVLVV GLPANGLALW VLATQAPRLP STMLLMNLAA
121 ADLLLALALP PRIAYHLRGQ RWPFGEAACR LATAALYGHM YGSVLLLAAV SLDRYLALVH
181 PLRARALRGR RLALGLCMAA WLMAAALALP LTLQRQTFRL ARSDRVLCHD ALPLDAQASH
241 WQPAFTCLAL LGCFLPLLAM LLCYGATLHT LAASGRRYGH ALRLTAVVLA SAVAFFVPSN
301 LLLLLHYSDP SPSAWGNLYG AYVPSLALST LNSCVDPFIY YYVSAEFRDK VRAGLFQRSP
361 GDTVASKASA EGGSRGMGTH SSLLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against F2RL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- lung: 33 nTPM
- thyroid gland: 19 nTPM
- breast: 19 nTPM
- adipose tissue: 19 nTPM
- kidney: 9.1 nTPM
- pancreas: 8.7 nTPM
Single-cell type
- platelets: 109 nCPM
- vascular endothelial cells: 97 nCPM
- megakaryocytes: 62 nCPM
- lymphatic endothelial cells: 49 nCPM
- megakaryocyte progenitors: 16 nCPM
- epididymal principal cells: 6.9 nCPM
Immune cell
- basophil: 2.9 nTPM
- neutrophil: 1.8 nTPM
- naive B-cell: 1.6 nTPM
- plasmacytoid DC: 1.6 nTPM
- NK-cell: 1.5 nTPM
- memory B-cell: 1.4 nTPM
Brain region
- hypothalamus: 7.4 nTPM
- cerebellum: 7.3 nTPM
- choroid plexus: 7.1 nTPM
- midbrain: 6.1 nTPM
- white matter: 6.1 nTPM
- cerebral cortex: 5.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about F2RL3.
Disease | ImmuneIEDB
Conditions an epitope on F2RL3 was assayed in.
- hepatitis B T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- 0.19
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- G protein-coupled receptor signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
- platelet activation
- platelet aggregation
- platelet dense granule organization
- positive regulation of release of sequestered calcium ion into cytosol
- response to wounding
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads F2RL3 as an antibody target. Whether an autoantibody or antibody against F2RL3 could matter depends on whether native F2RL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
F2RL3 is annotated at the cell surface, where native F2RL3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label F2RL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...